AnalystsAndrea Tan
Andrea Tan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4768 out of 4867 analysts
Average Return
-16.02%
Win Rate
32%11 out of 34
Risk vs Reward
Poor
Good

Andrea Tan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Insmed IncINSM
+186.40%$24.93$71.40
2024-05-15 -
2025-04-29
Strong Buy
Relmada Therapeutics IncRLMD
+90.41%$2.96$0.28
2024-06-05 -
2025-04-29
Strong Sell
Fate Therapeutics IncFATE
+79.03%$14.21$2.98
2022-12-15 -
2023-12-14
Strong Sell
Krystal Biotech IncKRYS
+69.74%$104.78$177.85
2023-11-20 -
2024-11-19
Strong Buy
Codiak Biosciences IncCDAKQ
+68.78%$9.29$15.68
2020-11-09 -
2021-11-08
Strong Buy

Andrea Tan Analyst Color

Get additional color on Andrea Tan's coverage of popular stocks

Andrea Tan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Iovance Biotherapeutics IncIOVA
6Strong Buy$16.00+345.68%Maintains
14 days ago
Day One Biopharmaceuticals IncDAWN
6Strong Buy$27.00+247.04%Maintains
a month ago
Tarsus Pharmaceuticals IncTARS
3Hold$41.00-21.02%Maintains
6 months ago
Insmed IncINSM
5Strong Buy$102.00+41.67%Maintains
10 months ago
Sagimet Biosciences IncSGMT
5Hold$6.00+73.91%Maintains
10 months ago
Arrowhead Pharmaceuticals IncARWR
1Hold$31.00+123.18%Initiates Coverage On
a year ago
Relmada Therapeutics IncRLMD
3Strong Sell$2.00+521.12%Downgrades
a year ago
Kodiak Sciences IncKOD
1Strong Sell$2.00N/AReinstates
a year ago
Immunogen IncIMGN
1Hold$17.00N/AInitiates Coverage On
a year ago
Krystal Biotech IncKRYS
1Strong Buy$160.00N/AInitiates Coverage On
a year ago
Abcellera Biologics IncABCL
2Strong Buy$24.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
2Strong Sell$4.00N/AMaintains
2 years ago
Madrigal Pharmaceuticals IncMDGL
1Strong Buy$375.00N/AMaintains
2 years ago
Verve Therapeutics IncVERV
1Strong Sell$13.00N/AInitiates Coverage On
2 years ago
Codiak Biosciences IncCDAKQ
5Hold$1.40N/AMaintains
2 years ago
Vor Biopharma IncVOR
1Hold$6.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.